|
242
|
946
|
4hleA |
Compound 21 (1-alkyl-substituted 1,2,4-triazoles) |
|
190
|
529
|
4zdzA |
Saccharomyces cerevisiae cyp51 (lanosterol 14-alpha demethylase) y140f mutant complexed with fluconazole |
|
33
|
106
|
4xzqC |
Nucleosome disassembly by rsc and swi/snf is enhanced by h3 acetylation near the nucleosome dyad axis |
|
48
|
124
|
4ziaA |
Crystal structure of stat3 n-terminal domain |
|
27
|
79
|
4xzqB |
Nucleosome disassembly by rsc and swi/snf is enhanced by h3 acetylation near the nucleosome dyad axis |
|
52
|
206
|
4zgeB |
Double mutant h80w/h81w of fe-type nitrile hydratase from comamonas testosteroni ni1 |
|
47
|
129
|
4zeeA |
X-ray structure of the bis-platinum lysozyme adduct formed in the reaction between the protein and the two drugs cisplatin and oxaliplatin (preparation 2) |
|
90
|
270
|
4zlzA |
Crystal structure of bruton's tyrosine kinase in complex with a substituted cinnoline |
|
168
|
430
|
4zi7B |
Crystal structure of tubulin-stathmin-ttl-hti286 complex |
|
77
|
217
|
4zjrA |
Rorgamma in complex with inverse agonist 48 |
|
44
|
151
|
4zygA |
Crystal structure of methylated sulfolobus solfataricus o6-methylguanine methyltransferase |
|
227
|
581
|
4z69A |
Human serum albumin complexed with palmitic acid and diclofenac |
|
98
|
298
|
4ztmA |
Irak4-inhibitor co-structure |
|
157
|
460
|
4zfbA |
Cytochrome p450 pentamutant from bm3 bound to palmitic acid |
|
81
|
320
|
4zauA |
Azd9291 complex with wild type egfr |
|
113
|
402
|
4z7hA |
Crystal structure of human ire1 cytoplasmic kinase-rnase region - complex with imidazopyridine compound 3 |
|
86
|
283
|
4zjvA |
Crystal structure of egfr kinase domain in complex with mitogen-inducible gene 6 protein |
|
48
|
168
|
4z7fA |
Crystal structure of folt bound with folic acid |
|
164
|
439
|
4zi7A |
Crystal structure of tubulin-stathmin-ttl-hti286 complex |
|
31
|
93
|
4zyfA |
Discovery of nvp-cgm097 - a highly potent and selective mdm2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: hdm2 (mdm2) complexed with nvp-cgm097 |
|
85
|
267
|
4zibA |
Crystal structure of the c-terminal domain of pylrs mutant bound with 3-benzothienyl-l-alanine and atp |
|
242
|
652
|
4z3zA |
Active site complex bambc of benzoyl coenzyme a reductase in complex with zinc |
|
103
|
273
|
4z6yA |
Structure of the tbc1d7-tsc1 complex |
|
334
|
1059
|
4hnuA |
Crystal structure of k442e mutant of s. aureus pyruvate carboxylase |
|
54
|
155
|
4zihA |
Crystal structure of core/latch dimer of bax in complex with bimbh3mini |
|
89
|
270
|
4zlyA |
Crystal structure of bruton's tyrosine kinase bound to a cinnoline fragment |
|
77
|
294
|
4zloA |
Serine/threonine-protein kinase pak1 complexed with a dibenzodiazepine: identification of an allosteric site on pak1 |
|
104
|
402
|
4z7gA |
Crystal structure of human ire1 cytoplasmic kinase-rnase region - apo |
|
55
|
206
|
4zgjB |
Double mutant h80a/h81a of fe-type nitrile hydratase from comamonas testosteroni ni1 |
|
56
|
156
|
4zifA |
Crystal structure of core/latch dimer of bax in complex with bimbh3mini |
|
164
|
468
|
4zwgA |
Crystal structure of the gtp-datp-bound catalytic core of samhd1 phosphomimetic t592e mutant |
|
153
|
460
|
4zfaA |
Cytochrome p450 wild type from bm3 with bound peg |
|
29
|
98
|
4xzqA |
Nucleosome disassembly by rsc and swi/snf is enhanced by h3 acetylation near the nucleosome dyad axis |
|
50
|
129
|
4zfpA |
A new crystal structure for the adduct formed in the reaction between ausac2, a cytotoxic homoleptic gold(i) compound with the saccharinate ligand, and the model protein hen egg white lysozyme |
|
90
|
244
|
4zn7A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with diethylstilbestrol |
|
127
|
391
|
4z5qA |
Crystal structure of the lnmz cytochrome p450 hydroxylase from the leinamycin biosynthetic pathway of streptomyces atroolivaceus s-140 at 1.8 a resolution |
|
251
|
653
|
4z3yA |
Active site complex bambc of benzoyl coenzyme a reductase in complex with benzoyl-coa |
|
78
|
239
|
4zkiA |
The crystal structure of histidine kinase yycg with adp |
|
162
|
439
|
4zhqA |
Crystal structure of tubulin-stathmin-ttl-mmae complex |
|
30
|
91
|
4zyiA |
Discovery of nvp-cgm097 - a highly potent and selective mdm2 inhibitor undergoing phase 1 clinical trials in p53wt tumors: hdm2 (mdm2) complexed with cpd2 |
|
129
|
397
|
4zn6A |
X-ray crystal structure of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (ispc) from acinetobacter baumannii |
|
96
|
243
|
4ypqA |
Crystal structure of the ror(gamma)t ligand binding domain in complex with 4-(1-(2-chloro-6-(trifluoromethyl)benzoyl)-1h-indazol-3-yl)benzoic acid |
|
57
|
141
|
4yu4A |
Crystal structure of mongoose (helogale parvula) hemoglobin at ph 7.0 |
|
134
|
393
|
4z5pA |
Crystal structure of the lnma cytochrome p450 hydroxylase from the leinamycin biosynthetic pathway of streptomyces atroolivaceus s-140 at 1.9 a resolution |
|
121
|
469
|
4z1mD |
Bovine f1-atpase inhibited by three copies of the inhibitor protein if1 crystallised in the presence of thiophosphate. |
|
48
|
129
|
4yemA |
Carboplatin binding to hewl in nabr crystallisation conditions studied at an x-ray wavelength of 0.9163a - new refinement |
|
100
|
355
|
4yr8A |
Crystal structure of jnk in complex with a regulator protein |
|
51
|
129
|
4z3mA |
X-ray structure of the adduct formed in the reaction between lysozyme and a platinum(ii) complex with s,o bidentate ligands (9b) |
|
87
|
214
|
4ymwC |
Crystal structure of an amino acid abc transporter with histidines |
|
71
|
196
|
4z21A |
Crystal structure of arno sec7 |
